APPLICATIONS PUBLISHED 21 AUGUST 2002
Published: 1-Feb-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Modular targeted liposomal delivery system
The Liposome Company 1231895*
Taste masked oral compsns
Ranbaxy Laboratories 1231896*
Drug preparations
L.A.M. Pharmaceuticals 1231897*
Apparatus and method for preparing microparticles
Alkermes Controlled Therapeutics 1231898*
Multilayer preparation for a controlled, pulsed release of active substances
LTS Lohmann Therapie-Systeme 1221899*
Bilayered buccal tablets comprising nicotine
The Robert Gordon University 1231900*
Edible coating compsn
FMC Corp 1231901*
Film coating method for tablets
Sanofi-Synthelabo 1231902*
Coating of tablet cores
Biochemie 1231903*
A method of microencapsulation
Tagra Biotechnologies 1231904*
Responsive polymeric hollow particles
BioCure 1231905*
Transdermal therapeutic system containing highly volatile active ingredients
Hexal 1231906*
Dextrose and insulin fluid formulation for intravenous infusion
Gangal, Hanamaraddi 1231907*
Pharmaceutical compsn comprising NO or at least a NO donor compound or another compound capable of releasing or inducing NO formation in cells
Centre National de la Recherche Scientifique 1231908*
Use of ubiquinone Q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies
Simonelli, Giuseppe 1231909*
Inhibitors of endo-exonuclease activity such as pentamidine for treating cancer
Oncozyme Pharma 1231910*
Directly compressible, ultra fine acetaminophen compsns and process for producing same
Rhodia 1231911*
Injectable preparation for controlling fish live comprising benzoyl urea derivatives
Novartis 1231912*
Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
Pharmacia 1231913*
Nordihydroguaiaretic derivatives for use in treatment of tumours
Johns Hopkins University 1231914*
Use of Pleuromutilin derivatives for transdermal treatment of bacterial diseases
Novartis 1231915*
Use of indirubine derivatives for making medicines
Centre National de la Recherche Scientifique 1231916*
Pharmaceutical formulation comprising a thiazolidinedione-metformin hydrochloride
SmithKline Beecham 1231917*
Novel compsn based on a thiazolidinedione and metformin and use
SmithKline Beecham 1231918*
Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
Sloan-Kettering Insitute for Cancer Research; The Trustees of Columbia University in the City of New York 1231919*
Solutions containing epinastine
Boehringer Ingelheim Pharma 1231920*
Protease inhibitors
SmithKline Beecham 1231921*
Treatment of systemic lupus erythematosus (SLE) with dehydroepianrosterone
Genelabs Technologies 1231924*
Method and compsn for the treatment of adenoviral ocular infections
Wadell, Goeran; Arnberg, Niklas 1231925*
New complex and methods for its production and use
Jederstroem, Gustaf 1231926*
Nontoxic verbix compsns and method of producing
Children's Hospital Medical Centre 1231927*
Phytotherapeutic compsn for improving the condition and the immune system of a human or animal with this compsn
Brandes, Maria; Brandes, Jacobus 1231928*
Antiviral compsn
Henderson Morley 1231929*
Human IGM antibodies to chemokine receptors
Monicaid 1231930*
Methods of treating inflammatory bowel disease using cholera toxin B subunit
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services 1231931*
Implantable substrates for healing connective tissue
Transtissue Technologies 1231932*
An aqueous solution formulation of alpha-interferon
LG Chem Investment 1231933*
Methods of inhibiting atrophy or promoting hypertrophy
Regeneron Pharmaceuticals 1231934*
Attenuation of tumour growth, metastasis and angiogenesis by use of chrondroitin sulphate degrading enzymes
Ibex Technologies 1231935*
Methods and compsns for treatment of kreatoconus using protease inhibitors
K-Quay Enterprises 1231936*
TR3-specific binding agents and their use
Tittle, Thomas; Wegmann, Keith 1231937*
Oncolytic combinations for the treatment of cancer
Eli Lilly 1231938*
Stable amorphous amifostine compsn, and preparation thereof
Medimmune Oncology 1231940*
Tablets comprising micro-organisms and method for preparation of the tablets
Wasa Medicals 1231941*
Cobalamin conjugates useful as imaging agents and as antitumour agents
Mayo Foundation for Medical Education and Research; Regents of the University of Minnesota 1231942*
Interferon gamma conjugates
Maxygen Holdings 1231943*
Targeted delivery of therapeutic and diagnostic moieties
University of South Carolina 1231944*
Method and apparatus for anti-microbial and related treatments
UMP 1231945*
Injectable bone-substitute material
Universitaetsklinikum Freiburg 1231947*
A propellant-free spray-on skin patch compsn for improving wound healing and for drug administration
Ever Power Holding 1231948*
Particulate construct for use in the transplantation field
Medusa Beteiligungsverwaltungs-Gesellschaft 1231949*
Use of phthalazine derivatives
BASF 1231982*
Treatment of subnormal bone mineral density
Genelabs Technologies 1231983*
Phorboxazole derivatives for treating cancer
Parker Hughes Institute 1231984*
Method for preparing a polyaromatic compound
Rhodia Chemie 1232140*
Esters of O-desmethyl venlafaxine
Wyeth 1232141*
Method for isolating amido acid sulphonates out of water-solvent mixtures
Siemens Axiva 1232142*
Method for preparing dimetal sulphonyl amide salts
EI du Pont de Nemours 1232143*
Novel IL-8 receptor antagonists
Fournier Industrie et Sante 1232144*
Method for producing hyroxymethylpyridines
DSM Fine Chemicals 1232145*
4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline to treat colorectal cancer
Parker Hughes Institute 1232146*
Triazoles as farnesyl transferase inhibitors
Janssen Pharmaceutica 1232147*
Use of benzotriazole UV absorbers
Ciba Specialty Chemicals 1232148*
Urea derivatives as anti-inflammatory agents
Boehringer Ingelheim Pharmaceuticals 1232150*
Method for making benzofuranone oximes
Bayer 1232151*
Improved process for preparing nitrogen-substituted aminotetralins
Aderis Pharmaceutical 1232152*
Imidazole derivatives and their use as RAF kinase inhibitors
SmithKline Beecham 1232153*
Protease inhibitors
SmithKline Beecham 1232154*
Novel 1,2,3]-triazole 4,5-D]pyrimidine compounds
AstraZeneca 1232156*
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
Epoch Biosciences 1232157*
Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use
Merckle 1232158*
Beta-amyloid peptide inhibitors
Biomolecular Research Institute; The University of Melbourne 1232159*
Spiro (2H-1-benzopyran-2,4'-piperidine) derivatives as glycine transport inhibitors
Akzo Nobel 1232160*
